Broadview Advisors LLC reduced its stake in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) by 54.4% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 463,650 shares of the software maker’s stock after selling 553,600 shares during the period. Broadview Advisors LLC owned 0.26% of Allscripts Healthcare Solutions worth $5,916,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in the business. FNY Partners Fund LP raised its position in shares of Allscripts Healthcare Solutions by 900.0% in the first quarter. FNY Partners Fund LP now owns 8,000 shares of the software maker’s stock valued at $101,000 after purchasing an additional 7,200 shares during the period. Invictus RG acquired a new stake in shares of Allscripts Healthcare Solutions during the 1st quarter worth about $105,000. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in shares of Allscripts Healthcare Solutions by 9.5% during the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,434 shares of the software maker’s stock worth $120,000 after buying an additional 816 shares during the last quarter. Bank of Montreal Can lifted its stake in shares of Allscripts Healthcare Solutions by 60.2% during the 1st quarter. Bank of Montreal Can now owns 9,914 shares of the software maker’s stock worth $126,000 after buying an additional 3,724 shares during the last quarter. Finally, Virtu Financial LLC acquired a new stake in shares of Allscripts Healthcare Solutions during the 2nd quarter worth about $134,000.

MDRX has been the subject of several research analyst reports. Dougherty & Co reaffirmed a “buy” rating and set a $16.00 target price (up previously from $15.00) on shares of Allscripts Healthcare Solutions in a report on Tuesday. Cantor Fitzgerald reissued a “buy” rating and issued a $17.00 price target (up from $15.00) on shares of Allscripts Healthcare Solutions in a report on Monday, August 14th. Citigroup Inc. increased their price target on shares of Allscripts Healthcare Solutions from $13.00 to $14.00 and gave the company a “neutral” rating in a report on Monday, August 7th. Royal Bank Of Canada initiated coverage on shares of Allscripts Healthcare Solutions in a research report on Tuesday, September 19th. They set an “outperform” rating and a $17.00 price objective for the company. Finally, BidaskClub upgraded shares of Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a research report on Saturday, June 24th. One research analyst has rated the stock with a sell rating, eight have given a hold rating and twelve have given a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus price target of $15.29.

Allscripts Healthcare Solutions, Inc. (MDRX) traded up 0.14% during midday trading on Wednesday, reaching $14.37. 633,049 shares of the company traded hands. The firm’s market capitalization is $2.60 billion. The firm has a 50-day moving average price of $13.43 and a 200-day moving average price of $12.55. Allscripts Healthcare Solutions, Inc. has a one year low of $9.80 and a one year high of $14.45.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last issued its earnings results on Thursday, August 3rd. The software maker reported $0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.15 by ($0.04). The business had revenue of $426.10 million for the quarter, compared to the consensus estimate of $424.94 million. Allscripts Healthcare Solutions had a negative net margin of 11.54% and a positive return on equity of 5.97%. The company’s revenue was up 10.2% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.14 EPS. Equities analysts predict that Allscripts Healthcare Solutions, Inc. will post $0.62 EPS for the current fiscal year.

In other news, President Richard J. Poulton sold 15,000 shares of Allscripts Healthcare Solutions stock in a transaction on Friday, September 15th. The stock was sold at an average price of $13.56, for a total value of $203,400.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Brian Farley sold 5,000 shares of the business’s stock in a transaction on Thursday, September 14th. The shares were sold at an average price of $13.52, for a total value of $67,600.00. Following the sale, the executive vice president now owns 196,607 shares in the company, valued at $2,658,126.64. The disclosure for this sale can be found here. Insiders sold 35,000 shares of company stock valued at $473,800 over the last ninety days. Corporate insiders own 0.75% of the company’s stock.

WARNING: This report was published by Watch List News and is owned by of Watch List News. If you are reading this report on another domain, it was illegally copied and reposted in violation of U.S. and international copyright and trademark law. The legal version of this report can be read at https://www.watchlistnews.com/broadview-advisors-llc-decreases-holdings-in-allscripts-healthcare-solutions-inc-mdrx/1608172.html.

Allscripts Healthcare Solutions Profile

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Want to see what other hedge funds are holding MDRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX).

Institutional Ownership by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.